JP2004525928A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525928A5
JP2004525928A5 JP2002574739A JP2002574739A JP2004525928A5 JP 2004525928 A5 JP2004525928 A5 JP 2004525928A5 JP 2002574739 A JP2002574739 A JP 2002574739A JP 2002574739 A JP2002574739 A JP 2002574739A JP 2004525928 A5 JP2004525928 A5 JP 2004525928A5
Authority
JP
Japan
Prior art keywords
dosage form
nicotine
sugar alcohol
active
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002574739A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004525928A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/008914 external-priority patent/WO2002076211A1/en
Publication of JP2004525928A publication Critical patent/JP2004525928A/ja
Publication of JP2004525928A5 publication Critical patent/JP2004525928A5/ja
Pending legal-status Critical Current

Links

JP2002574739A 2001-03-26 2002-03-22 ニコチン含有経口剤形 Pending JP2004525928A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27860601P 2001-03-26 2001-03-26
PCT/US2002/008914 WO2002076211A1 (en) 2001-03-26 2002-03-22 Nicotine-containing oral dosage form

Publications (2)

Publication Number Publication Date
JP2004525928A JP2004525928A (ja) 2004-08-26
JP2004525928A5 true JP2004525928A5 (enrdf_load_stackoverflow) 2005-12-22

Family

ID=23065632

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002574739A Pending JP2004525928A (ja) 2001-03-26 2002-03-22 ニコチン含有経口剤形

Country Status (11)

Country Link
EP (1) EP1372392A4 (enrdf_load_stackoverflow)
JP (1) JP2004525928A (enrdf_load_stackoverflow)
CN (2) CN101301275A (enrdf_load_stackoverflow)
AR (1) AR033444A1 (enrdf_load_stackoverflow)
AU (1) AU2002252470B2 (enrdf_load_stackoverflow)
BR (1) BR0208382A (enrdf_load_stackoverflow)
CA (1) CA2440713A1 (enrdf_load_stackoverflow)
MX (1) MXPA03008762A (enrdf_load_stackoverflow)
NZ (1) NZ528167A (enrdf_load_stackoverflow)
PL (1) PL364621A1 (enrdf_load_stackoverflow)
WO (1) WO2002076211A1 (enrdf_load_stackoverflow)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
TW200514579A (en) * 2003-07-24 2005-05-01 Smithkline Beecham Corp Orally dissolving films
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
MX2007001609A (es) * 2004-08-11 2009-02-12 Cadbury Adams Usa Llc Composiciones perceptibles y sistemas de liberacion de las mismas.
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US7780981B2 (en) 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
EP2101744A2 (en) * 2006-12-01 2009-09-23 Cima Labs Inc. Oral transmucosal nicotine dosage form
GB2468424B (en) * 2007-04-02 2011-11-09 Parkinson S Inst Methods and compositions for reduction of side effects of therapeutic treatments
JP2010523587A (ja) 2007-04-02 2010-07-15 パーキンソンズ インスティテュート 治療処置の副作用の低減のための方法および組成物
DE102008012015A1 (de) * 2008-03-01 2009-09-10 Südzucker AG Mannheim/Ochsenfurt Verbesserte Isomalt-haltige Komprimate und Verfahren zu ihrer Herstellung
WO2011101860A1 (en) * 2010-02-18 2011-08-25 Jatin Vasant Thakkar Nicotine-containing soft gelatin pastilles
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
UA112974C2 (uk) 2010-09-16 2016-11-25 Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид Нікотиновмісна композиція (варіанти)
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
AR096223A1 (es) * 2013-05-10 2015-12-16 Glaxosmithkline Llc Pastilla de nicotina para administración oral
CN104132895B (zh) * 2014-07-08 2017-08-25 国家烟草质量监督检验中心 适用于连续流动法测定烟草及烟草制品中总植物碱的缓冲体系
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
SE541358C2 (en) * 2017-05-30 2019-08-13 Enorama Pharma Ab Nicotine-containing chewing gum compositions
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
MY207783A (en) * 2019-06-07 2025-03-18 Philip Morris Products S A Nicotine pouch composition
CN115003281A (zh) * 2020-01-15 2022-09-02 麦克内尔股份公司 锭剂
US20220313678A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Spray dried nicotine for inclusion in oral products
USD1081739S1 (en) 2021-04-06 2025-07-01 Altria Client Services Llc Die for gum forming
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
DE19536394A1 (de) * 1995-09-29 1997-04-03 Basf Ag Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze
DE19639342C2 (de) * 1996-09-25 1998-07-16 Suedzucker Ag Kaugummi, enthaltend ein Süßungsmittel
US6322806B1 (en) * 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center

Similar Documents

Publication Publication Date Title
JP2004525928A5 (enrdf_load_stackoverflow)
JP2006503046A5 (enrdf_load_stackoverflow)
EP1082106B1 (en) Effervescent tablet for the sublingual, buccal and gingival administration of fentanyl
RU2216319C1 (ru) Быстрорастворимая фармацевтическая композиция в виде твердой лекарственной формы с пролонгированным сладким вкусом и способ ее получения
JP2006516648A5 (enrdf_load_stackoverflow)
AU2002252470B2 (en) Nicotine-containing oral dosage form
US20040101543A1 (en) Nicotine-containing oral dosage form
JP2007523091A5 (enrdf_load_stackoverflow)
AU2003267268B2 (en) Modified release oral dosage form
AU627775B2 (en) Pharmaceutical compositions
RU2000107784A (ru) Препараты для орального введения
AU2002252470A1 (en) Nicotine-containing oral dosage form
JPH0786086B2 (ja) 薬剤組成物
UA57615C2 (uk) Тверда шипуча швидкорозчинна композиція цетиризину
WO1996000070A1 (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with an oral composition containing nicotine and caffeine or xanthine
UA53714C2 (uk) Спосіб отримання таблеток флурбіпрофену
FI4288036T3 (fi) Plasman kallikreiinin estäjän formulaatioita
JP2002332229A (ja) 感冒用組成物
US10016359B2 (en) Solid forms containing meloxicam with improved buccal taste and process for their preparation
JP2004043475A (ja) 経口用セファロスポリン製剤
ES2242940T3 (es) Prucaloprida n-oxido.
JP2005503429A5 (enrdf_load_stackoverflow)
ES2215025T3 (es) Formulacion farmaceutica efervescente, que contiene metamizol.
JP2005507409A5 (enrdf_load_stackoverflow)
CZ122593A3 (en) Pharmaceutical preparation